{"entity":"astrazeneca","name":"AstraZeneca","kind":"people","summary":"AstraZeneca's timeline holds 1 people claim from 2012. The latest took effect on October 1, 2012.","counts":{"total":66,"by_kind":{"people":1,"money":56,"products":0,"models":0,"other":9}},"events":[{"date":"2012-10-01","until":null,"published":"2012-09-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"AstraZeneca ceo: Pascal Soriot\", as of 2012-10-01. Claim clm_5E921CD2E098, https://asof.is/claim/clm_5E921CD2E098, accessed 2026-11-10. Source: https://www.astrazeneca.com/our-company/leadership.html.","url":"https://asof.is/claim/clm_5E921CD2E098","accessed":"2026-11-10"},"kind":"people","predicate":"ceo","value":"Pascal Soriot","status":"valid","assertable":true,"id":"clm_5E921CD2E098","evidence":{"by":"page-read","on":"2026-11-09","quote":"Pascal Soriot will take on his new responsibilities and join the AstraZeneca PLC Board as an Executive Director on 1 October 2012. Simon Lowth will remain as AstraZeneca’s Interim Chief Executive Officer until Pascal Soriot joins.","url":"https://www.sec.gov/Archives/edgar/data/0000901832/000095010312004497/dp32579_6k.htm"}}],"complete":true,"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"page-read":"its source page states the value and the date"}}}